Skip to main content
Premium Trial:

Request an Annual Quote

The Catch-22: To Debate It You Have to Cite It

Michael Eisen has a post at his It Is Not Junk blog taking on a paper from James Evans that suggests that free access to literature has little effect on citations. "This paper ... has many flaws," Eisen writes, proceeding with his list of "the most egregious." For one thing, Eisen says, citation rates aren't the best measure of the value of free access -- and for another, he notes, the raw data haven't been made available for other scientists to perform their own analyses. (Maybe the authors didn't think making their data available would improve their citation rate.)

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.